Odyssey Therapeutics (NASDAQ:ODTX) Releases Earnings Results

Odyssey Therapeutics (NASDAQ:ODTX) released its earnings results on Wednesday. The company reported $999.00 earnings per share (EPS) for the quarter, Zacks reports.

Odyssey Therapeutics Price Performance

Odyssey Therapeutics stock traded up $0.61 during mid-day trading on Wednesday, hitting $18.48. 471,191 shares of the company’s stock were exchanged, compared to its average volume of 324,281. Odyssey Therapeutics has a 1-year low of $15.35 and a 1-year high of $20.30.

Wall Street Analyst Weigh In

ODTX has been the subject of several recent research reports. Wedbush initiated coverage on Odyssey Therapeutics in a report on Tuesday, June 2nd. They set an “outperform” rating and a $30.00 price objective for the company. Wall Street Zen upgraded Odyssey Therapeutics to a “hold” rating in a report on Saturday, May 16th. Cantor Fitzgerald initiated coverage on Odyssey Therapeutics in a report on Tuesday, June 2nd. They set an “overweight” rating for the company. Zacks Research upgraded Odyssey Therapeutics to a “hold” rating in a report on Wednesday, June 3rd. Finally, JPMorgan Chase & Co. initiated coverage on Odyssey Therapeutics in a report on Tuesday, June 2nd. They set an “overweight” rating and a $26.00 price objective for the company. Five analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Odyssey Therapeutics currently has an average rating of “Moderate Buy” and a consensus target price of $32.00.

Insider Activity

In other Odyssey Therapeutics news, Director Shelley Chu bought 11,111 shares of the stock in a transaction on Monday, May 11th. The shares were purchased at an average cost of $18.00 per share, with a total value of $199,998.00. Following the completion of the transaction, the director directly owned 11,111 shares of the company’s stock, valued at $199,998. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Sr One Capital Management, Llc bought 555,555 shares of the stock in a transaction on Monday, May 11th. The shares were acquired at an average cost of $18.00 per share, for a total transaction of $9,999,990.00. Following the completion of the transaction, the insider directly owned 1,831,383 shares of the company’s stock, valued at approximately $32,964,894. The trade was a 43.54% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders acquired 4,183,777 shares of company stock valued at $75,319,986.